Industry News
Biotechnology Industry News

Biopharma charts progress in translating CAR-T cell therapies to solid cancers
Biopharma charts progress in translating CAR-T cell therapies to solid cancers arlene.weintraub Thu, 12/09/2021 - 10:20
ASH: 2 years in, the survival data on J&J’s rival to Bristol Myers’ BCMA cell therapy are still growing
ASH: 2 years in, the survival data on J&J's rival to Bristol Myers' BCMA cell therapy are still growing ntaylor Thu, 12/09/2021 - 09:25
ASH: Novartis posts early clinical data on next-gen CAR-Ts, sets sights on 2022 registration trials
ASH: Novartis posts early clinical data on next-gen CAR-Ts, sets sights on 2022 registration trials ntaylor Thu, 12/09/2021 - 09:18
K36 emerges with $30M to bankroll multiple myeloma drug in-licensed from Novartis
K36 emerges with $30M to bankroll multiple myeloma drug in-licensed from Novartis klahucik Thu, 12/09/2021 - 08:31
Totus tots up $40M in series A funding to go after competitive cancer space
Totus tots up $40M in series A funding to go after competitive cancer space ntaylor Thu, 12/09/2021 - 08:15
ASH: Senti Bio’s gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models
ASH: Senti Bio's gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models aliu Thu, 12/09/2021 - 07:40
Novartis works on pan-coronavirus pill, eyes 2022 human testing
Novartis works on pan-coronavirus pill, eyes 2022 human testing badams Thu, 12/09/2021 - 04:34
Science, talent, money: Eir raises $138M VC fund to fill gap in Nordic life science scene
Science, talent, money: Eir raises $138M VC fund to fill gap in Nordic life science scene ntaylor Wed, 12/08/2021 - 10:50
Fresh from $316M raise, Sotio inks Merck deal for Keytruda combo trial
Fresh from $316M raise, Sotio inks Merck deal for Keytruda combo trial ntaylor Wed, 12/08/2021 - 08:38
Merck KGaA steps up VC activity with $677M investment, positioning M Ventures to keep pace with changing landscape
Merck KGaA steps up VC activity with $677M investment, positioning M Ventures to keep pace with changing landscape ntaylor Wed, 12/08/2021 - 03:52
J&J squares up to Big Pharma rivals with extra RSV vaccine data
J&J squares up to Big Pharma rivals with extra RSV vaccine data ntaylor Tue, 12/07/2021 - 08:01
Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy
Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy ntaylor Tue, 12/07/2021 - 05:44
Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multipronged R&D strategy
Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multipronged R&D strategy ntaylor Tue, 12/07/2021 - 05:44
Avistone nabs $200M cancer platform funding drive from leading VCs as it combines with Pearl Biotech
Avistone nabs $200M cancer platform funding drive from leading VCs as it combines with Pearl Biotech badams Tue, 12/07/2021 - 04:13
GlaxoSmithKline, Medicago hit 75% efficacy against delta COVID strain, but omicron muddies waters
GlaxoSmithKline, Medicago hit 75% efficacy against delta COVID strain, but omicron muddies waters badams Mon, 12/06/2021 - 14:55
Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise
Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise elucas Mon, 12/06/2021 - 13:42
Could Viagra prevent and treat Alzheimer’s? Cleveland Clinic team shows its potential
Could Viagra prevent and treat Alzheimer's? Cleveland Clinic team shows its potential arlene.weintraub Mon, 12/06/2021 - 09:57
Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role
Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role badams Mon, 12/06/2021 - 09:48
Investors punish Aeglea for missed rare disease secondaries, sending stock spiraling despite primary endpoint success
Investors punish Aeglea for missed rare disease secondaries, sending stock spiraling despite primary endpoint success ntaylor Mon, 12/06/2021 - 08:58
Adicet soars on early responses to gamma delta CAR-T therapy
Adicet soars on early responses to gamma delta CAR-T therapy ntaylor Mon, 12/06/2021 - 08:19

